Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2019030610) DIRECTLY COMPRESSIBLE DUAL DRUG RELEASING PHARMACEUTICAL COMPOSITIONS
Latest bibliographic data on file with the International BureauSubmit observation

Pub. No.: WO/2019/030610 International Application No.: PCT/IB2018/055700
Publication Date: 14.02.2019 International Filing Date: 31.07.2018
IPC:
A61K 9/00 (2006.01) ,A61K 31/155 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9
Medicinal preparations characterised by special physical form
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
13
Amines, e.g. amantadine
155
Amidines (), e.g. guanidine (H2N-C(NH)-NH2), isourea (HNC(OH)NH2), isothiourea (HNC(SH)-NH2)
Applicants:
SOLUTIONS IN INNOVATIVE RESEARCH PVT. LTD. [IN/IN]; 602, Eternelle, Baner Road, Pune 411045, IN
Inventors:
KHANDARE, Jayant Jagannath; IN
GOTHOSKAR, Abhijit; IN
ALAND, Gourishankar; IN
Agent:
SANTHANAM, Kausalya; IN
Priority Data:
20172102873611.08.2017IN
Title (EN) DIRECTLY COMPRESSIBLE DUAL DRUG RELEASING PHARMACEUTICAL COMPOSITIONS
(FR) COMPOSITIONS PHARMACEUTIQUES À LIBÉRATION DE MÉDICAMENT DOUBLE DIRECTEMENT COMPRESSIBLES
Abstract:
(EN) This invention relates to a direct compressible (DC) dual drug releasing composition as pharmaceutical formulation in the form of granules or tablet. The present invention is directed to Active Pharmaceutical Ingredients (APIs) in dual- Immediate (IR) and Extended release (ER) profiles which comprises single excipient with APIs:Excipient ratio and method of preparation thereof. The pharmaceutical formulation is directed to increase patient compliance by reducing formulation excipeints and improve swallowing ability in children and patients with dysphagia.
(FR) La présente invention concerne une composition à libération de médicament double directement compressible (DC) en tant que formulation pharmaceutique sous la forme de granules ou de comprimés. La présente invention concerne des principes pharmaceutiques actifs (API) dans des profils à libération immédiate (IR) et à libération prolongée (ER) doubles qui comprennent un excipient unique avec un rapport API/excipient, et leur procédé de préparation. La formulation pharmaceutique est destinée à augmenter la conformité du patient en réduisant des excipients de formulation, et améliorer la capacité de déglutition chez les enfants et les patients atteints de dysphagie.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)